Education
About Us
Working with TipRanks
Follow Us
Rabia Gurses Ozden Insider Profile
4 Followers
Rabia Gurses Ozden, CMO at Adverum Biotechnologies, holds 8.13K shares in Adverum Biotechnologies (Ticker: ADVM), holds 153.05K shares in Ocular Therapeutix (Ticker: OCUL).
Rabia Gurses Ozden Adverum Biotechnologies (ADVM)CMO
Adverum Biotechnologies (ADVM)
CMO
Ranked #29,811 out of 100,956 Corporate Insiders
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+16.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Rabia Gurses Ozden holds in companies
Most Profitable Insider Trade
The most profitable trade made by Rabia Gurses Ozden
Rabia Gurses Ozden's Trading History
Adverum Biotechnologies
Feb 27, 2025
CMO
Uninformative Buy
―
$37.21K
Ocular Therapeutix
Feb 06, 2024
CMO
Uninformative Buy
―
$1.15M
List of latest transactions for each holding click on a transaction to see Rabia Gurses Ozden's performance on stock
You May Also Like
Rabia Gurses Ozden insider profile FAQ
What is the percentage of profitable transactions made by Rabia Gurses Ozden?
The percentage of profitable transactions made by Rabia Gurses Ozden is 67%.
What is the average return per transaction made by Rabia Gurses Ozden?
The average return per transaction made by Rabia Gurses Ozden is 16.70%.
What stocks does Rabia Gurses Ozden hold?
Rabia Gurses Ozden holds: ADVM, OCUL stocks.
What was Rabia Gurses Ozden’s latest transaction?
Rabia Gurses Ozden latest transaction was an Uninformative Buy of ―.
What was Rabia Gurses Ozden's most profitable transaction?
Rabia Gurses Ozden’s most profitable transaction was an Informative Buy of OCUL stock on February 6, 2024. The return on the trade was 51.50%.
What is Rabia Gurses Ozden's role in Adverum Biotechnologies?
Rabia Gurses Ozden's role in Adverum Biotechnologies is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.